Pancreatic Cancer Research

ResearcherKyoto Prefectural University of MedicineNo recent work listed

Hidekazu Hiramoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8377-5204; OpenAlex author ID A5043387644. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 2 papers

Papers 2

  1. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Co-author DOI 10.1038/s41598-017-04191-w↗
  2. [A Case of Gemcitabine and Nab-Paclitaxel Therapy for Multiple Metastatic Pancreatic Cancer]. Co-author PMID 29394789↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Johji Inazawa · 1 shared paper, 2017 · strength 0.08
  2. Daisuke Ichikawa · 1 shared paper, 2017 · strength 0.08
  3. Eigo Otsuji · 1 shared paper, 2017 · strength 0.08
  4. Mamoru Masuyama · 1 shared paper, 2017 · strength 0.07
  5. Yusuke Takashima · 1 shared paper, 2017 · strength 0.07
  6. Jun Shibamoto · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.